期刊文献+

贝那普利联合活血通络方治疗糖尿病肾病的效果观察及分析 被引量:7

原文传递
导出
摘要 目的通过对贝那普利联合活血通络方治疗糖尿病肾病的效果观察及分析,探讨其作用机制、提高治疗效果。方法将76例糖尿病肾病患者按随机数字表法分为对照组和试验组,每组38例,两组患者均给予常规治疗,试验组在此基础上给予贝那普利联合活血通络方治疗,对两组的临床治疗效果、中医症状评分、24h尿微量白蛋白、Br微球蛋白、血尿素氮、血肌酐水平以及血液流变学指标、生活质量评分进行观察和分析。结果试验组治疗总有效率为92.11%(35/38),高于对照组的73.68%(28/38),差异有统计学意义(P〈0.05);两组治疗后中医症状评分、24h尿微量白蛋白、Br微球蛋白、血尿素氮、血肌酐水平以及血液流变学指标比较差异有统计学意义(P〈0.05);两组治疗后肾病给生活带来的负担、社交质量、症状与不适、肾病对日常生活的影响、睡眠质量、工作状况比较差异有统计学意义(P〈O.05)。结论贝那普利联合活血通络方治疗糖尿病肾病效果显著,值得临床推广应用。
出处 《中国医师进修杂志》 2013年第7期40-42,共3页 Chinese Journal of Postgraduates of Medicine
  • 相关文献

参考文献6

二级参考文献51

  • 1李静,李荣山.巨噬细胞在大鼠糖尿病肾病发病机制中的作用[J].中国中西医结合肾病杂志,2005,6(2):79-82. 被引量:10
  • 2余堂宏,贾汝汉,陈健,熊燕,丁国华.霉酚酸酯对2型糖尿病大鼠肾脏单核细胞趋化蛋白-1表达的影响[J].中国中西医结合肾病杂志,2005,6(4):192-194. 被引量:8
  • 3王成,娄探奇,唐骅,彭晖,刘迅,游宇平,陈珠江,余学清.双重阻断肾素-血管紧张素系统对慢性肾脏疾病血压、蛋白尿和肾功能的影响[J].中华肾脏病杂志,2006,22(7):398-401. 被引量:35
  • 4中华人民共和国卫生部.中药新药治疗消渴病(糖尿病)的临床研究指导原则[S].,1987.215~218.
  • 5Mogensen CE.Early diabetic renal involvement and nephathy[A].In:Alberthy KGMM,Krall LP.The Diabtes Annual[M].Vol3,Qmsterdam,Elsevier Sceince Publishers,1987.306.
  • 6Boussagean R, Bejan-Angoulvant T, Saadatian-Elahi M, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials. BMJ, 2011, 343 :d4169.
  • 7Molitch ME, DeFronzo RA, Franz MJ, et al. Nephropathy in diabetes. Diabetes Care, 2004, 27 Suppl l :S79-83.
  • 8Macisaac RJ, Jeruros G. Intensive glucose control and cardiovascular outcomes in type 2 diabetes. Heart Lung Circ, 201 l, 20(10) : 647-654.
  • 9Kasthuri RS, Glover SL, Boles J, et al. Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays. Semin Thromb Hemost, 2010,36(7):764-771.
  • 10Lwaleed BA, Francis JL, Chisholm M. Urinary tissue factor levels in patients with bladder and prostate cancer. Eur J Surg Oncol, 2000, 26( 1 ) :44-49.

共引文献317

同被引文献45

  • 1King DE,Mainous AG,Egan BM,et al.Use of statins pressure[J].Am J Hypertens,2007,20(9):937-941.
  • 2Hakim FA,Ptlueger A.Role of oxidative stress in diabetic kidneydisease[J].Med Sci Monit,2010,16(2):A37-48.
  • 3Stehouwer CDA,Schaper NC.The pathogenesis of vascular com-plications of diabetes me] litus:one voice or many[J].Eur J ClinInvest,1996,26(7):535-543.
  • 4Fujii M,Inoguchi T,Maeda Y,et,al.Pitavastatinameli orates al-bum in uria and renal mesangial expansion by down regulatingN0X4 in db /db mice[J].Kidney Int,2007,72(4):473-480.
  • 5Campese VM,Park J.HMG-CoA reductase inhibitors and the kid-ney[J].Kidney Int,2007,71(12):1215-1222.
  • 6Jones PH,Davidson MH,Stein EA,et al.Comparison ofthe effica-cy and safety of rosuvastatin versus atorvastatin,simvastatin,andpravastatin across doses(STELLAR Trial)[J].Am J Cardiol,2003,92(1):152-160.
  • 7Orchard TJ,Chang YF,Ferrell RE,et al.Nephropathy in type 1 diabetes:a manifestation of insulin resistance and multiple genetic susceptibilities? Further evidence from the Pittsburgh Epidemiology of Diabetes Complication Study[J].Kidney Int,2002,62 (3):963-970.
  • 8Mykkǎnen L,Zaccaro DJ,Wagenknecht LE,et al.Microalbuminuria is associated with insulin resistance in nondiabetic subjects:the insulin resistance atherosclerosis study[J].Diabetes,1998,47 (5):793-800.
  • 9Cho BH,Yu H,Kim KW,et al.Application of irregular and unbalanced data to predict diabetic nephropathy using visualization and feature selection methods[J].Artif Intell Med,2008,42 (1):37-53.
  • 10Hsieh MC,Tien K J,Perng DS,et al.Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus[J].Metabolism,2009,58(4):504-509.

引证文献7

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部